Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:OPKO_Health
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:CEO |
gptkb:Jon_R._Cohen
|
| gptkbp:foundedYear |
1981
|
| gptkbp:founder |
gptkb:Dr._Marc_D._Grodman
|
| gptkbp:headquartersLocation |
gptkb:Elmwood_Park,_New_Jersey,_United_States
|
| gptkbp:industry |
gptkb:clinical_laboratory
|
| gptkbp:notableEvent |
COVID-19 testing expansion in 2020
|
| gptkbp:numberOfEmployees |
over 3000
|
| gptkbp:parentCompany |
gptkb:OPKO_Health
|
| gptkbp:servesArea |
gptkb:United_States
|
| gptkbp:services |
genetic testing
anatomic pathology clinical testing |
| gptkbp:stockSymbol |
BRLI (former, NASDAQ)
|
| gptkbp:subsidiary |
gptkb:GenPath_Diagnostics
gptkb:GeneDx |
| gptkbp:website |
https://www.bioreference.com/
|
| gptkbp:bfsParent |
gptkb:Quest_Diagnostics
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioReference Laboratories
|